Bank of America
JUNO

Bank of America’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bank of America’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-54,400
Closed -$2.07M – 7592
2016
Q1 		$2.07M Buy
+54,400
New +$1.9M ﹤0.01% 3529
2015
Q3 		– Sell
-85,100
Closed -$4.54M – 7593
2015
Q2 		$4.54M Buy
+85,100
New +$4.52M ﹤0.01% 2675

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of America's JUNO Position: Q1 2018 in Review

Bank of America sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 104,449 shares — an estimated $4.78M sold.

Bank of America first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $4.78M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Bank of America reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 104,449 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4.78M.
  • Bank of America first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
  • Bank of America's Juno Therapeutics, Inc. position peaked at $4.78M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.